Literature DB >> 12117124

Why is there a quality chasm?

Joseph P Newhouse1.   

Abstract

Medical care seems to obtain less value from the resources it uses than other industries do, a phenomenon not limited to the United States. I explore several reasons for this, including consumers' ignorance, the rate of technological change, the widespread use of administered pricing, the difficulty of appraising a given provider's quality, and the role of the public sector with objectives other than efficiency. Although these causes suggest that the performance of medical care may always lag behind that of other industries, greater use of information technology and improved financial incentives will help to reduce the size of the quality chasm.

Mesh:

Year:  2002        PMID: 12117124     DOI: 10.1377/hlthaff.21.4.13

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  9 in total

1.  Improving the process through which health plans and providers exchange performance-related mammography data.

Authors:  Gerry Fairbrother; James Luciano; Heidi L Park
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  A perinatal care quality and safety initiative: are there financial rewards for improved quality?

Authors:  Katy B Kozhimannil; Samantha A Sommerness; Phillip Rauk; Rebecca Gams; Charles Hirt; Stanley Davis; Kristi K Miller; Daniel V Landers
Journal:  Jt Comm J Qual Patient Saf       Date:  2013-08

Review 3.  Ethics in American health 2: an ethical framework for health system reform.

Authors:  Jennifer Prah Ruger
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

4.  Performance measurement in healthcare: part II--state of the science findings by stage of the performance measurement process.

Authors:  Carol E Adair; Elizabeth Simpson; Ann L Casebeer; Judith M Birdsell; Katharine A Hayden; Steven Lewis
Journal:  Healthc Policy       Date:  2006-07

5.  Modest risk-sharing significantly reduces health plans' incentives for service distortion.

Authors:  Shuli Brammli-Greenberg; Jacob Glazer; Ruth Waitzberg
Journal:  Eur J Health Econ       Date:  2019-08-22

Review 6.  Pay-for-Performance: Disappointing Results or Masked Heterogeneity?

Authors:  Adam A Markovitz; Andrew M Ryan
Journal:  Med Care Res Rev       Date:  2016-08-03       Impact factor: 3.929

7.  Funding of US biomedical research, 2003-2008.

Authors:  E Ray Dorsey; Jason de Roulet; Joel P Thompson; Jason I Reminick; Ashley Thai; Zachary White-Stellato; Christopher A Beck; Benjamin P George; Hamilton Moses
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

8.  Balanced performance measurement in research hospitals: the participative case study of a haematology department.

Authors:  Simona Catuogno; Claudia Arena; Sara Saggese; Fabrizia Sarto
Journal:  BMC Health Serv Res       Date:  2017-08-03       Impact factor: 2.655

9.  Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment.

Authors:  Ilene L Hollin; Jennifer Gerard Ball
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.